Search
Cimetidine
go.drugbank.com/drugs/DB00501ApprovedInvestigationalA histamine congener, it competitively inhibits histamine binding to histamine H2 receptors. Cimetidine has a range of pharmacological actions.
Synonyms: N''-cyano-N-methyl-N'-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine, N-cyano-N'-methyl-N''-(2-([(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl)ethyl)guanidineCategories: Hepatotoxic Agents, Less DILI ConcernGlycerin
go.drugbank.com/drugs/DB09462ApprovedInvestigationalA trihydroxy sugar alcohol that is an intermediate in carbohydrate and lipid metabolism.
Mixtures: No More Products, Peptide no sebum RepairCategories: Non-Standardized Chemical AllergenMetoprolol
go.drugbank.com/drugs/DB00264ApprovedInvestigational[A175159, L5530] The possibility of the generation of these formulations comes from the lower systemic bioavailability of the succinate derivative. … [A175162] Metoprolol was developed since 1969 by US Pharmaceutical Holdings I and FDA approved in 1978.[L5527]
Categories: Hepatotoxic Agents, Less DILI ConcernProducts: Nu-metoprolol, Nu-metoprolol SRDiltiazem
go.drugbank.com/drugs/DB00343ApprovedInvestigationalApproved in 1982 by the FDA, it is a member of the non-dihydropyridine calcium channel blockers drug class. … It works through various mechanisms of action, but it primarily works by inhibiting the calcium influx into cardiac and vascular smooth muscle during depolarization.
Categories: Hepatotoxic Agents, Most DILI ConcernProducts: Nu-diltiaz Tab 30mg, Nu-diltiaz Tab 60mgMedroxyprogesterone acetate
go.drugbank.com/drugs/DB00603ApprovedInvestigational[L8657,L8660,L8663,L8666,L8669] Medroxyprogesterone acetate was granted FDA approval on 18 June 1959.[L8657] … Medroxyprogesterone acetate (MPA) is a [progesterone] derivative that is more resistant to metabolism for improved pharmacokinetic properties.
Products: Nu-medroxy, NON-PREG INJECTIONTrihexyphenidyl
go.drugbank.com/drugs/DB00376ApprovedInvestigational[L31843] It has largely been replaced by drugs such as [levodopa].[L31843] Trihexyphenidyl was granted FDA approval on 13 May 1949.[L31768] … [A229103] Trihexyphenidyl is rarely used in the treatment of parkinsonism, and is not a first line treatment due to significant adverse effects.
Products: Nu-trihexyphenidylFenofibrate
go.drugbank.com/drugs/DB01039ApprovedInvestigational[A185954] Fenofibrate is used to treat primary hypercholesterolemia, mixed dyslipidemia, severe hypertriglyceridemia.[L8588,L8591] Fenofibrate was granted FDA approval on 31 December 1993.[L8585]
Categories: Non-statin Hypolipidemic Agents Indicated for Hyperlipidemia, Hepatotoxic Agents, Less DILI ConcernProducts: Nu-feno-micro, SUPRALIP NT 145 MGZopiclone
go.drugbank.com/drugs/DB01198ApprovedInvestigationalIts mechanism of action is based on modulating benzodiazepine receptors. In addition to zopiclone's benzodiazepine pharmacological properties it also has some barbiturate-like properties.
Products: Nu-zopiclone, Nu-zopiclone Tablets - 7.5mgAscorbic acid
go.drugbank.com/drugs/DB00126ApprovedInvestigationalNutraceuticalIts biologically active form, vitamin C, functions as a reducing agent and coenzyme in several metabolic pathways. Vitamin C is considered an antioxidant. … A six carbon compound related to glucose. It is found naturally in citrus fruits and many vegetables.
Mixtures: Super Daily No 2, Formula No. 2 Plus K LiqProducts: Nn Vitamin C-100, CEVIT NF GOTAS 100MG/MLAnti-inhibitor coagulant complex
go.drugbank.com/drugs/DB13151ApprovedInvestigationalIt is used to control bleeding in hemophilia A and B patients with inhibitors.
Products: Feiba Nf